Key Metrics
CiteScore 

3.5
Impact Factor 

< 5
Scite Index 

0.86 5-Year SI

SNIP 

1.14
Recommended pre-submission checks
Powered by 

Topics Covered on Current Oncology
Current Oncology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | MDPI |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | CHF 1800 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Current Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Oncology
High-Grade Glioma Tumoral Cells in a Case of Postoperative, Recurrent Subdural Hematoma… Where Did They Come From?
- 10 May 2026
- Current Oncology
Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study
- 5 May 2026
- Current Oncology
The Implementation of a Caregiver Distress Screening Initiative in a Pediatric Oncology Healthcare Setting: A Quality Improvement Project
- 28 Apr 2026
- Current Oncology
Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”
- 27 Apr 2026
- Current Oncology
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients
- 26 Apr 2026
- Current Oncology
A Case of Primary EGFR T790M Mutation in Treatment-Naïve Advanced NSCLC: Clinical and Molecular Implications
- 24 Apr 2026
- Current Oncology
High-Grade Glioma Tumoral Cells in a Case of Postoperative, Recurrent Subdural Hematoma… Where Did They Come From?
- 10 May 2026
- Current Oncology
Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study
- 5 May 2026
- Current Oncology
The Implementation of a Caregiver Distress Screening Initiative in a Pediatric Oncology Healthcare Setting: A Quality Improvement Project
- 28 Apr 2026
- Current Oncology
Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”
- 27 Apr 2026
- Current Oncology
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients
- 26 Apr 2026
- Current Oncology
A Case of Primary EGFR T790M Mutation in Treatment-Naïve Advanced NSCLC: Clinical and Molecular Implications
- 24 Apr 2026
- Current Oncology